A combination of the US drugmaker’s monoclonal antibodies bamlanivimab and etesevimab has been given approval for restricted use in emergency situations in hospital settings in adults.
Indian Daily
Bringing you you the latest news, opinions, headline, stories, trends & more in the country. Browse the site for up to date information on national, regional and world wide happenings from politics, business, economy, finance, sports, movies, lifestyle, travel, events, food and a lot more
